back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-01-25 23:29 Tx date 2023-01-24 |
$SZLS
StageZero Life Sciences Ltd. |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$91,455
+1,407,000 vol $0.065 each |
3,818,250 | |
| Filed 2023-01-25 23:27 Tx date 2023-01-24 |
$SZLS
StageZero Life Sciences Ltd. |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$49,725
+765,000 vol $0.065 each |
2,411,250 | |
| Filed 2021-08-20 21:30 Tx date 2021-08-19 |
$SZLS
StageZero Life Sciences Ltd. |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,763
+28,300 vol $0.345 each |
261,059 | |
| Filed 2020-12-23 23:21 Tx date 2020-12-22 |
$SZLS
StageZero Life Sciences Ltd. |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$24,000
+100,000 vol $0.24 each |
232,759 | |
| Filed 2020-12-23 23:20 Tx date 2020-12-22 |
$SZLS
StageZero Life Sciences Ltd. |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-24,000
-100,000 vol $0.24 each |
1,646,250 | |
| Filed 2020-12-22 22:04 Tx date 2020-12-22 |
$SZLS
StageZero Life Sciences Ltd. |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-12,223,750 vol |
1,746,250 | |
| Filed 2020-12-22 22:02 Tx date 2020-12-22 |
$SZLS
StageZero Life Sciences Ltd. |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-929,311 vol |
132,759 | |
| Filed 2020-08-10 21:50 Tx date 2020-08-07 |
$SZLS
StageZero Life Sciences Ltd. |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$275,000
+5,000,000 vol $0.055 each |
13,970,000 | |
| Filed 2019-08-31 12:41 Tx date 2019-08-23 |
$SZLS
StageZero Life Sciences Ltd. |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$408,500
+4,085,000 vol $0.10 each |
8,970,000 | |
| Filed 2018-07-03 Tx date 2018-06-28 |
$GEN
GeneNews Limited |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,000
+250,000 vol $0.08 each |
4,885,000 | |
| Filed 2018-07-03 Tx date 2018-05-28 |
$GEN
GeneNews Limited |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-20,416.34
-20,833 vol $0.98 each |
4,635,000 | |
| Filed 2018-04-04 Tx date 2018-04-02 |
$GEN
GeneNews Limited |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,000
+200,000 vol $0.11 each |
3,155,833 | |
| Filed 2018-04-04 Tx date 2018-04-02 |
$GEN
GeneNews Limited |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$165,000
+1,500,000 vol $0.11 each |
4,655,833 | |
| Filed 2017-07-14 Tx date 2017-07-14 |
$GEN
GeneNews Limited |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$64,588
+280,820 vol $0.23 each |
905,820 | |
| Filed 2017-07-14 Tx date 2017-07-14 |
$GEN
GeneNews Limited |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$35,937
+156,250 vol $0.23 each |
1,062,070 | |
| Filed 2017-07-14 Tx date 2017-07-14 |
$GEN
GeneNews Limited |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-35,937.50
-156,250 vol $0.23 each |
0 | |
| Filed 2017-07-04 Tx date 2017-06-30 |
$GEN
GeneNews Limited |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$23,750
+125,000 vol $0.19 each |
2,355,833 | |
| Filed 2017-07-04 Tx date 2017-06-30 |
$GEN
GeneNews Limited |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$114,000
+600,000 vol $0.19 each |
2,955,833 | |
| Filed 2017-06-12 Tx date 2017-04-26 |
$GEN
GeneNews Limited |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-12,000
-12,500 vol $0.96 each |
2,230,833 | |
| Filed 2016-09-06 Tx date 2016-09-01 |
$GEN
GeneNews Limited |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$78,125
+156,250 vol $0.50 each |
156,250 | |
| Filed 2016-09-06 Tx date 2003-06-01 |
$GEN
GeneNews Limited |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-09-06 Tx date 2016-09-01 |
$GEN
GeneNews Limited |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$100,000
+625,000 vol $0.16 each |
625,000 | |
| Filed 2016-08-12 Tx date 2016-08-10 |
$GEN
GeneNews Limited |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$77,900
+410,000 vol $0.19 each |
2,243,333 | |
| Filed 2016-08-12 Tx date 2016-05-16 |
$GEN
GeneNews Limited |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-14,250
-12,500 vol $1.14 each |
1,733,333 | |
| Filed 2016-07-05 Tx date 2016-06-30 |
$GEN
GeneNews Limited |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$17,000
+100,000 vol $0.17 each |
1,845,833 | |
| Filed 2015-12-23 Tx date 2015-12-22 |
$GEN
GeneNews Limited |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,000
+800,000 vol $0.03 each |
1,745,833 | |
| Filed 2015-08-20 Tx date 2015-07-08 |
$GEN
GeneNews Limited |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-19,001.52
-8,334 vol $2.28 each |
945,833 | |
| Filed 2015-05-27 Tx date 2015-05-25 |
$GEN
GeneNews Limited |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$32,000
+100,000 vol $0.32 each |
954,167 |